Literature DB >> 2996133

Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor.

F Leal, L T Williams, K C Robbins, S A Aaronson.   

Abstract

A scheme for partial purification of biologically active v-sis-coded protein from cells transformed with simian sarcoma virus (SSV) has made possible a functional comparison of the transforming protein with platelet-derived growth factor (PDGF). The SSV-transforming gene product is capable of specifically binding PDGF receptors, stimulating tyrosine phosphorylation of PDGF receptors, and inducing DNA synthesis in quiescent fibroblasts. Each of these activities was specifically inhibited by antibodies to different regions of the v-sis gene product. Moreover, viral infection of a variety of cell types revealed a strict correlation between those cells possessing PDGF receptors and those susceptible to transformation by SSV. These findings provide evidence that SSV-transforming activity is mediated by the interaction of a virus-coded mitogen with PDGF receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996133     DOI: 10.1126/science.2996133

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Authors:  T P Fleming; T Matsui; C J Molloy; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.

Authors:  J S Gutkind; E A Novotny; M R Brann; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.

Authors:  E Finzi; T Fleming; O Segatto; C Y Pennington; T S Bringman; R Derynck; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity.

Authors:  W J LaRochelle; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

5.  c-kit protein, a transmembrane kinase: identification in tissues and characterization.

Authors:  S Majumder; K Brown; F H Qiu; P Besmer
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

6.  The 5' untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor.

Authors:  C D Rao; M Pech; K C Robbins; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

7.  p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line.

Authors:  S Giordano; M F Di Renzo; R Ferracini; L Chiadò-Piat; P M Comoglio
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Structure and sequence of the human c-sis/platelet-derived growth factor 2 (SIS/PDGF2) transcriptional unit.

Authors:  C D Rao; H Igarashi; I M Chiu; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

Authors:  J T Holt; T V Gopal; A D Moulton; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 10.  Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation.

Authors:  B Westermark; C H Heldin
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.